FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
85 hedge funds and large institutions have $258M invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 18 closing their positions.
37% more capital invested
Capital invested by funds: $188M → $258M (+$69.7M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
9% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 32
10% less funds holding
Funds holding: 94 → 85 (-9)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
45% less call options, than puts
Call options by funds: $2.5M | Put options by funds: $4.55M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$11.5M |
| 2 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$7.33M |
| 3 |
RA
Royce & Associates
New York
|
+$6.85M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$4.6M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$3.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
-$1.83M |
| 2 |
6CM
683 Capital Management
New York
|
-$1.7M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.45M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.36M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.12M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PP
101
PDT Partners
New York
| – | -$251K | -7,364 | Closed |
|
102
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$274K | -6,628 | Closed |
|
|
CCM
103
Corsair Capital Management
New York
| – | -$190K | -5,586 | Closed |
|
|
BJ
104
BlackRock Japan
Tokyo,
Japan
| – | -$21K | -628 | Closed |
|
FURX Hedge Fund Activity: Q3 2013 in Review
85 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q3 2013, worth a combined $258M — up 37% from $188M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FURX and 10 opened new positions — a net loss of 8 holders — while 32 trimmed existing stakes and 29 added.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $11.5M. The largest seller was Global Alpha Capital Management, cutting an estimated $1.83M.
- 85 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q3 2013, down from 94 in Q2 2013.
- Funds reported $258M of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q3 2013, up 37% quarter-over-quarter.
- 10 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q3 2013 and 18 closed out, a net change of -8 holders.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2013 was Eagle Asset Management, an estimated $11.5M added.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q3 2013 was Global Alpha Capital Management, an estimated $1.83M sold.
Based on aggregated 13F filings for Q3 2013.